Position in IQV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,839,364
+$389,560 QoQ
Shares Held
14,695
+2.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#382
of 1,082 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $38,936,517 across 18 Diagnostics & Research names. IQV ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
21,998 | $11,028,912 | |
| 2 | NTRA |
Natera, Inc.
|
17,241 | $4,680,066 | |
| 3 | ILMN |
Illumina, Inc.
|
23,473 | $4,127,254 | |
| 4 | DHR |
Danaher Corp /De/
|
19,443 | $3,703,497 | |
| 5 | IQV |
Iqvia Holdings Inc.
This page
|
14,695 | $2,839,364 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
4,310 | $2,282,530 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
4,079 | $2,147,346 | |
| 8 | A |
Agilent Technologies, Inc.
|
14,793 | $1,964,951 |
All Filings in IQV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,839,364 | 14,695 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $2,449,804 | 14,365 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $3,937,910 | 17,470 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $3,012,256 | 15,859 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $2,401,041 | 15,236 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,206,773 | 6,845 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $843,617 | 4,293 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $766,124 | 3,233 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $962,686 | 4,553 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $895,230 | 3,540 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||